SPEC PerkinElmer 11.10
News|Articles|November 5, 2026

How Deep Low-Frequency Raman Could Detect Breast Microcalcifications

Mammograms can find breast microcalcifications but can’t tell whether they are likely benign or malignant.

At SciX 2026 in Sparks, Nevada, Spectroscopy spoke with Sara Miller, a vibrational spectroscopist at Flinders University in Australia.1 She and her co-authors Mitchell C. Chalmers, Teemu Tomberg, and Keith Gordon won the inaugural Peter Griffiths Award for the best paper in Applied Spectroscopy Practica. Their study used deep low-frequency Raman spectroscopy to tell apart model breast microcalcifications immersed in wax and placed under varying depths of it, with wax standing in for tissue as a proof of principle.1

Below is a transcript of our conversation with Miller, which highlights one way that Raman spectroscopy is being used in clinical workflows.

Congratulations on winning the Peter Griffiths Award for Best Publication in Applied Spectroscopy Practica. What does winning this award mean for you and your research?

It is a great honor for our research team. It’s nice to have recognition for the work that our research group and international collaboration have carried out.

Breast microcalcifications are described as clinically important but still poorly understood. What's the biggest misconception or unresolved debate in this space that your work is trying to address?

We're trying to address finding a different way of detecting the breast microcalcifications. A mammogram's really good at detecting the microcalcifications, but it can't distinguish whether it is likely to be benign or malignant. Additional biopsies and tests are required to figure that out. Therefore, we really want to use low-wavenumber Raman to see if we can get a fingerprint of the composition of those microcalcifications and if that could be used as a diagnostic tool.

Your award-winning paper focused on detecting microcalcifications through wax at varying depths using deep low-frequency Raman. What was the clinical or practical scenario that made “through wax, at depth” the right problem to solve, rather than a more standard surface measurement?

The ultimate goal is to be able to detect microcalcifications in breast tissue, and so that means we need to be able to detect these microcalcifications below some kind of tissue-like medium. We were really trying to find a proof of principle for this particular study, so we were using wax as our tissue phantom.

The defocused microspatially offset setup gave you the strongest results, with an AUC of 0.94 in the low-frequency region. What is a "defocused microspatially offset" setup, in practical terms, and why do you think it outperformed the other two experimental configurations?

The micro-spatially offset setup is where we are taking our Raman measurement, and we’re defocusing from there. That means that you’re starting to capture photons that have undergone Raman scattering across a larger volume and deeper into that substrate. We think that this particular alignment works the best because we’re still capturing a large volume of the photons that were scattered.

In the other alignments that we studied, which were using a lateral offset, we’re moving further away from the illumination laser point, and that means that the photons have to scatter further to be detected, and we’re only looking at a subset of those scattered photons. Therefore, we’re going to end up with more noise and less signal in that particular type of arrangement.

Model microcalcifications immersed in wax are a lab proxy for real tissue. What's the biggest remaining gap between what you demonstrated in the controlled model and what would be needed to apply this in an actual clinical breast imaging setting?

There are a few steps that have to occur before we get to that clinical setting. I think the first thing we need to do is look at a much more representative tissue phantom, whether that is some pork meat and skin, or whether we can utilize varying levels of pigment and hydrogels to try and mimic different skin colors and see how the photons can penetrate under those different conditions. We also need to create a probe that utilizes that type of setup that can be in a more portable system before we then take it to a clinic to even start to build the data to build the robust models.

What do the findings from your recent research projects mean for the future of using low-wavenumber Raman in medical diagnostics?

I think the findings are a good starting point and show promise. I think based on what we’ve found so far, it’s worth pursuing it further for any application where we think mineral-type subsurface signatures might be useful. While we’re targeting the breast microcalcifications, maybe bone-type measurements would be also useful, or even, say, roots of teeth; that may be another potential application as well.

Reference
  1. Miller, S.; Workman, J., Jr.; Wetzel, W. Sara Miller on Detecting Microcalcifications With Low-Frequency Raman. Spectroscopy Online, 2026. https://www.spectroscopyonline.com/view/sara-fraser-miller-on-detecting-microcalcifications-with-low-frequency-raman (accessed October 28, 2026).

Related to this article

Work of the surgeon in the hospital operating room. Concentrated doctor with glasses. | Image Credit: © velimir - stock.adobe.com
Jürgen Popp explains how head and neck surgeons in Jena use a Raman probe to locate tumor borders, why the technique could replace frozen section biopsies, and why optical tools must adapt to clinical workflows rather than the other way around.
Healthcare administrator reviewing an insurance policy schedule with a stethoscope on a clipboard, health insurance coverage, medical underwriting, prior authorization, and patient claims processing. | Image Credit: Joi_studio - stock.adobe.com
In a SciX interview, Marc Porter covered a lot of ground, from a student-driven pivot into immunoassays to a baseball analogy for Stokes and anti-Stokes scattering, and shares the open questions he is still chasing.